Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction

Short Title: 
MAT-PDOA
Initial Announcement
Funding Opportunity Announcement (FOA) Information
FOA Number: 
TI-17-017
Posted on Grants.gov: 
Wednesday, May 31, 2017
Application Due Date: 
Monday, July 31, 2017
Catalog of Federal Domestic Assistance (CFDA) Number: 
93.243
Intergovernmental Review (E.O. 12372): 
Applicants must comply with E.O. 12372 if their state(s) participates. Review process recommendations from the State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.
Public Health System Impact Statement (PHSIS) / Single State Agency Coordination: 
Applicants must send the PHSIS to appropriate State and local health agencies by application deadline. Comments from Single State Agency are due no later than 60 days after application deadline.
Description

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for fiscal year (FY) 2017 Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) grants. The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder seeking or receiving MAT. This program targets states identified with having the highest rates of primary treatment admissions for heroin and opioids per capita and includes those states with the most dramatic increases for heroin and opioids, based on SAMHSA’s Treatment Episode Data Set (TEDS): 2007 – 2014. The desired outcomes include: 1) an increase in the number of admissions for MAT; 2) an increase in the number of clients receiving integrated care/treatment; 3) a decrease in illicit opioid drug use at six-month follow-up; and 4) a decrease in the use of prescription opioids in a non-prescribed manner at six-month follow-up.

Eligibility

As the 2017 Omnibus requires, eligibility is limited to the states with the highest rates of admissions, including those that have demonstrated a dramatic increase in admissions for the treatment of opioid use disorder. See Appendix E for a list of eligible states. The application must be submitted by the Single State Agency (SSA) for Substance Abuse within the state. FY 2015 MAT-PDOA grantees funded under announcement TI-15-007 and FY 2016 MAT-PDOA grantees funded under announcement TI-16-014 are not eligible to apply for this program.

Award Information
Funding Mechanism: 
Grant
Anticipated Total Available Funding: 
$28 million
Anticipated Number of Awards: 
Up to 5 awards
Anticipated Award Amount: 
Up to $2 million per year
Length of Project: 
Up to three years.
Cost Sharing/Match Required?: 
No

Proposed budgets cannot exceed $2,000,000 in total costs (direct and indirect) in any year of the proposed project. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.

Contact Information
Program Issues

Kim Thierry
Public Health Advisor
Division of Services Improvement, Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
240-276-2907
kim.thierry@samhsa.hhs.gov

Grants Management and Budget Issues

Eileen Bermudez
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
240-276-1412
foacsat@samhsa.hhs.gov

Application Materials

You must respond to the requirements in both the FOA PART I and PART II when preparing your application.

Useful Information for Applicants

Last Updated: 06/22/2017